Cart
sales@molnova.com
LY2624803
CAS No. 879409-35-5
LY2624803 ( LY 2624803 )
Catalog No. M16382 CAS No. 879409-35-5
LY2624803 is a novel potent histamine H1 and 5HT-2A receptor modulator in the pipeline for treating insomnia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 324 | Get Quote |
|
| 10MG | 477 | Get Quote |
|
| 25MG | 773 | Get Quote |
|
| 50MG | 1062 | Get Quote |
|
| 100MG | 1431 | Get Quote |
|
| 500MG | 2871 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLY2624803
-
NoteResearch use only, not for human use.
-
Brief DescriptionLY2624803 is a novel potent histamine H1 and 5HT-2A receptor modulator in the pipeline for treating insomnia.
-
DescriptionLY2624803 is a novel potent histamine H1 and 5HT-2A receptor modulator in the pipeline for treating insomnia.Sleep Disorder Phase 2 Discontinued
-
SynonymsLY 2624803
-
PathwayGPCR/G Protein
-
TargetHistamine Receptor
-
RecptorHistamine Receptor
-
Research AreaNeurological Disease
-
IndicationSleep Disorder
Chemical Information
-
CAS Number879409-35-5
-
Formula Weight379.46
-
Molecular FormulaC22H25N3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(O)C(C)(C)CN1CCN(C2=NC3=CC=CC=C3OC4=CC=CC=C24)CC1
-
Chemical Name3-(4-benzo[b][1,4]benzoxazepin-6-ylpiperazin-1-yl)-2,2-dimethylpropanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zisapel N. Expert Opin Investig Drugs. 2015 Mar;24(3):401-11.
molnova catalog
related products
-
Betahistine mesylate
Betahistine is an antivertigo drug first used for treating vertigo assosicated with Ménière’s disease.
-
Ginsenoside Rb2
Ginsenoside Rb2 found in species of Panax, upregulating GPR120 gene expression.
-
Alcaftadine
A H1 histamine receptor antagonist that used for prevention of allergic conjunctivitis.
